drugset / Trial / NCT01826201

Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis

NCT01826201 ↗

Phase 2 Completed 21 enrolled Moleculin, LLC
NaSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether MOL4239 is effective in adult subjects with mild to moderate plaque psoriasis by comparing two target lesions in which each subject will apply MOL4239 ointment to one target lesion and placebo ointment to the contralateral target lesion twice a day for 28.5 consecutive days.

Timeline

Start
2013-03
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject MOL4239 Small molecule 10 % Topical

Indications